Gastric Cancer

, Volume 20, Issue 6, pp 998–1003 | Cite as

A cumulative effect involving malfunction of the PTH1R and ATP4A genes explains a familial gastric neuroendocrine tumor with hypothyroidism and arthritis

  • Oriol Calvete
  • Maite Herraiz
  • Jose Reyes
  • Ana Patiño
  • Javier Benitez
Short Communication

Abstract

Background

Type I gastric neuroendocrine tumors (gNETs) classically arise because of hypergastrinemia and involve destruction of parietal cells, which are responsible for gastric acid secretion through the ATP4A proton pump and for intrinsic factor production.

Methods

By whole exome sequencing, we studied a family with three members with gNETs plus hypothyroidism and rheumatoid arthritis to uncover their genetic origin.

Results

A heterozygous missense mutation in the ATP4A gene was identified. Carriers of this variant had low ferritin and vitamin B12 levels but did not develop gNETs. A second heterozygous mutation was also uncovered (PTH1R p.E546K). Carriers exhibited hypothyroidism and one of them had rheumatoid arthritis. Gastrin activates parathyroid hormone like hormone/parathyroid hormone 1 receptor (PTH1R) signaling, which is involved in gastric cell homeostasis. Activation of parathyroid hormone/PTH1R, which is upregulated by thyrotropin in the thyroid, is also involved in RANKL expression, which regulates bone homeostasis. Thyrotropin and RANKL expression were deregulated in PTH1R mutation carriers, suggesting a link between the PTH1R gene, hypothyroidism, rheumatoid arthritis, and gastric disease. Only patients with both mutations developed gNETs plus hypothyroidism and rheumatoid arthritis.

Conclusion

Both mutations suggest that a collaborative mechanism is operative in this family, in which mutations in these genes affect the function and viability of parietal cells and lead to the achlorhydria that drives hypergastrinemia and the formation of gNETs.

Keywords

Gastric neuroendocrine tumor PTH1R ATP4A Hypothyroidism Rheumatoid arthritis 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethics approval

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions.

Informed consent

Informed consent was obtained from all patients included in the study.

Funding

Javier Benitez’s laboratory is partially funded by the Spanish Center for Biomedical Network Research on Rare Diseases (CIBERER), the H2020 BRIDGES project, and the Spanish Ministry of Health (PI12/00070 and PI16/00440).

Supplementary material

10120_2017_723_MOESM1_ESM.jpg (422 kb)
Supplementary material 1 (JPEG 422 kb)
10120_2017_723_MOESM2_ESM.docx (73 kb)
Supplementary material 2 (DOCX 72 kb)
10120_2017_723_MOESM3_ESM.docx (31 kb)
Supplementary material 3 (DOCX 30 kb)
10120_2017_723_MOESM4_ESM.docx (51 kb)
Supplementary material 4 (DOCX 51 kb)

References

  1. 1.
    Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: pathologist’s viewpoint. World J Gastroenterol. 2015;21(42):12179–89.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Pritchard DM, Berry D, Przemeck SMC, Campbell F, Edwards SW, Varro A. Gastrin increases mcl-1 expression in type I gastric carcinoid tumors and a gastric epithelial cell line that expresses the CCK-2 receptor. Am J Physiol Gastrointest Liver Physiol. 2008;295:G798–805.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Liu C, Chen J, Guo Y, Yang L, Zhao C, Bai L. The expression of PTHLH in human gastric mucosa enterochromaffin-like cells. Dig Dis Sci. 2011;56:993–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Zhao CM, Kodama Y, Flatberg A, Beisvag V, Kulseng B, Sandvik AK, et al. Gene expression profiling of gastric mucosa in mice lacking CCK and gastrin receptors. Regul Pept. 2014;192:35–44.CrossRefPubMedGoogle Scholar
  5. 5.
    Wysolmerski JJ. Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab. 2012;97:2947–56.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Aasarød KM, Mosti MP, Stunes AK, Reseland JE, Basso T, Syversen U, et al. Impaired skeletal health in patients with chronic atrophic gastritis. Scand J Gastroenterol. 2016;51:774–81.CrossRefPubMedGoogle Scholar
  7. 7.
    Collins AB, Pawlak R. Prevalence of vitamin B12 deficiency among patients with thyroid dysfunction. Asia Pac J Clin Nutr. 2016;25:221–6.PubMedGoogle Scholar
  8. 8.
    Calvete O, Reyes J, Zuñiga S, Paumard-Hernández B, Fernández V, Bujanda L, et al. Exome sequencing identifies ATP4A gene as responsible of an atypical familial type I gastric neuroendocrine tumour. Hum Mol Genet. 2015;24:2914–22.CrossRefPubMedGoogle Scholar
  9. 9.
    Calvete O, Varro A, Pritchard DM, Barroso A, Oteo M, Morcillo MÁ, et al. A knockin mouse model for human ATP4a R703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies. Dis Models Mech. 2016;9(9):975–84.CrossRefGoogle Scholar
  10. 10.
    Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25:402–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Yachdav G, Kloppmann E, Kajan L, Hecht M, Goldberg T, Hamp T, et al. PredictProtein-an open resource for online prediction of protein structural and functional features. Nucleic Acids Res. 2014;42:W337–43.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Ho PWM, Goradia a, Russell MR, Chalk a M, Milley KM, Baker EK, et al. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo. Oncogene. 2014. doi: 10.1038/onc.2014.217.Google Scholar
  13. 13.
    Solter D, Solter M. Thyrotropin and thyroid hormone economy in euthyroid Hashimoto’s thyroiditis. Acta Clin Croat. 2015;54:52–6.PubMedGoogle Scholar
  14. 14.
    Witrand A, Scaramuzzino S, Nigon D, Lukas C, Allanore Y, Vittecoq O, et al. Association of polymorphisms on OPG, rank and RANKL with ACPA presence and erosions: results of a meta-analysis on 1570 rheumatoid arthritis patients from 3 French cohorts. Arthritis Rheumatol. 2014;66:S500–1.Google Scholar
  15. 15.
    Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58:15–25.CrossRefPubMedGoogle Scholar

Copyright information

© The International Gastric Cancer Association and The Japanese Gastric Cancer Association 2017

Authors and Affiliations

  • Oriol Calvete
    • 1
    • 2
  • Maite Herraiz
    • 3
  • Jose Reyes
    • 4
  • Ana Patiño
    • 5
  • Javier Benitez
    • 1
    • 2
  1. 1.Human Genetics GroupSpanish National Cancer Research Center (CNIO)MadridSpain
  2. 2.Biomedical Research Networking Center on Rare Diseases (CIBERER)MadridSpain
  3. 3.Department of GastroenterologyUniversity Clinic of NavarraPamplonaSpain
  4. 4.Department of GastroenterologyHospital INCAMajorcaSpain
  5. 5.Department of Pediatrics and Clinical Genetics UnitUniversity Clinic of NavarraPamplonaSpain

Personalised recommendations